DelveInsight has launched a new report on Cerebral Adrenoleukodystrophy Epidemiology
Cerebral Adrenoleukodystrophy (ALD) is an X-linked recessive genetic disorder caused by the abnormality in the ABCD1 gene present on the X chromosome that leads to the accumulation of very-long-chain fatty acids (VLCFAs) in the brain, nervous system, and adrenal gland.
Get a free sample copy- https://www.delveinsight.com/report-store/cerebral-adrenoleukodystrophy-cald-epidemiology-forecast
An all-inclusive account of both the current and Cerebral Adrenoleukodystrophy emerging therapies for Cerebral Adrenoleukodystrophy, along with the assessment of new therapies, which will have an impact on the current treatment landscape.
Cerebral Adrenoleukodystrophy Epidemiology
Cerebral Adrenoleukodystrophy is a genetic disorder that occurs primarily in males. It mainly affects the nervous system and the adrenal glands, which are small glands located on top of each kidney. In this disorder, the fatty covering (myelin) that insulates nerves in the brain and spinal cord is prone to deterioration (demyelination), which reduces the ability of the nerves to relay information to the brain.
Key facts of the Cerebral Adrenoleukodystrophy report
Cerebral Adrenoleukodystrophy Epidemiology Segmentation
Cerebral Adrenoleukodystrophy Symptoms
The symptoms of CALD include learning disabilities, behavioral problems, bowel incontinence, adrenal insufficiency, loss of vision, deafness, seizures, loss of brain and muscle tissue.
Cerebral Adrenoleukodystrophy Treatment
General supportive care and symptomatic treatment for patient and family, provided by pediatrician or neurologist, with appropriate specialist consultation, nursing, schools, rehabilitation, and social agencies, are the cornerstones for the care and treatment of patients with CALD. Currently, there are no approved therapies for the treatment of CALD, and it is primarily managed by hormone replacement therapy, dietary therapy with Lorenzo’s oil, and Hematopoietic stem cell transplantation.
Get a free sample copy – https://www.delveinsight.com/report-store/cerebral-adrenoleukodystrophy-cald-epidemiology-forecast
Table of content
1. Key Insights
2. Executive Summary of Cerebral Adrenoleukodystrophy (CALD)
3. Cerebral Adrenoleukodystrophy (CALD): Disease Background and Overview
4. Patient Journey
5. Epidemiology and Patient Population
6. Treatment Algorithm, Current Treatment, and Medical Practices
7. KOL Views
8. Unmet Needs
9. Appendix
10. DelveInsight Capabilities
11. Disclaimer
12. About DelveInsight
Reasons to buy
The Cerebral Adrenoleukodystrophy (CALD) Epidemiology report will allow the user to –
Related Reports
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Yash BhardwajEmail: Send EmailPhone: +919650213330Address:304 S. Jones Blvd #2432 City: Las VegasState: NVCountry: United StatesWebsite: https://www.delveinsight.com/